Marshall Wace has taken a publicly disclosed short position equivalent to 0.51 percent of the capital in medical technology company Raysearch Laboratories.
There are six publicly disclosed short sellers in the company. In total, 9.19 percent of the capital in the company is shorted.
The Swedish Financial Supervisory Authority requires positions above 0.1 percent to be reported, and short positions above 0.5 percent to be publicly disclosed.
